Administration of combined diphtheria and tetanus toxoids and pertussis vaccine, hepatitis B vaccine, and Haemophilus influenzae type b (Hib) vaccine to infants and response to a booster dose of Hib conjugate vaccine

Clinical Infectious Diseases

Volumn 25, Issue 6, 1997, Pages 1378-1384

  Pichichero, Michael E ^a   Passador, Sherry ^a  

^a UNIVERSITY OF ROCHESTER MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DIPHTHERIA TOXOID; HAEMOPHILUS INFLUENZAE TYPE B VACCINE; HEPATITIS B VACCINE; PERTUSSIS VACCINE; TETANUS TOXOID;

ANTIBODY RESPONSE; ANTIBODY TITER; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; INFANT; MAJOR CLINICAL STUDY; MULTICENTER STUDY; PRIORITY JOURNAL; RADIOIMMUNOASSAY; RANDOMIZED CONTROLLED TRIAL; VACCINATION;

EID: 0031451968     PISSN: 10584838     EISSN: None     Source Type: Journal    
DOI: 10.1086/516154     Document Type: Article

References (7)

1. Eskola J, Ölander RM, Hovi T, Litmanen L, Peltola S, Käyhty H. Randomised trial of the effect of co-administation with acellular pertussis DTP vaccine on immunogenicity of Haemophilus influenzae type b conjugate vaccine. Lancet 1996;348:1688-92.
2. Greenberg DP, Wong VK, Partridge S, Howe BJ, Jing J, Ward JI. Evaluation of a new combination vaccine that incorporates diphtheria-tetanusacellular pertussis (DTaP), hepatitis B (HB) and Haemophilus influence type b (Hib) conjugate (PRP-T) vaccines [abstract no G70]. In: Program and abstracts of the 35th Interscience Conference on Antimicrobial Agents and Chemotherapy (San Francisco). Washington, DC: American Society for Microbiology, 1995:170.
3. Schmitt HJ. Immunogenicity and reactogenicity of 2 Hib tetanus conjugate vaccines administered by reconstituting with DTPa or given as separate injections [abstract no G63]. In: Program and abstracts of the 35th Interscience Conference on Antimicrobial Agents and Chemotherapy (San Francisco). Washington, DC: American Society for Microbiology, 1995:169.
4. Shinefield H, Black S, Ray P, et al. Safety of combined acellular pertussis DTaP-HbOC vaccine (Lederle-Praxis) in infants [abstract no G72]. In: Program and abstracts of the 35th Interscience Conference on Antimicrobial Agents and Chemotherapy (San Francisco). Washington, DC: American Society for Microbiology, 1995:171.
5. Pichichero ME, Latiolais T, Bernstein DI, et al. Safety and immunogenicity of a combination DTaP/PRP-T vaccine in 2, 4 and 6 month-old infants. Pediatr Infect Dis J 1997;16:863-70.
6. Daum RS. Efficacy of the combined diphtheria-tetanus toxoids-pertussis-Haemophilus conjugate vaccine. Pediatr Infect Dis J 1995;14:640-1.
7. Clemens J, Brenner R, Rao M. Interactions between PRP-T vaccine against Haemophilus influenzae type b and conventional infant vaccines: lessons for future studies of simultaneous immunization and combined vaccines. Ann NY Acad Sci 1995;754:255-66.